3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
42
INDUSTRY
7
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Gastric Adenocarcinoma
1
Interventions
tislelizumab
12
Capecitabine
8
apatinib
5
Surgical Procedures, Operative
5
Carboplatin
5
Oxaliplatin
4
Drug Therapy
4
Cisplatin
4
Paclitaxel
3
Immunotherapy
3
Bevacizumab
3
anlotinib
2
Standard of Care
2
Radiotherapy
2
Radiation
2
Methods
2
Melphalan
2
Low-Level Light Therapy
2
Letrozole
2
Interleukin-2
2
Injections
2
Cryotherapy
2
zanubrutinib
1
trastuzumab deruxtecan
1
toripalimab
1
sintilimab
1
pyrotinib
1
pertuzumab
1
obinutuzumab
1
nedaplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
OTHER_GOV
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT07610629
2026-05-28
RA-A-NP
Henan Cancer Hospital
Phase 2
Not yet recruiting
50 enrolled